Singh Om Prakash, Hasker Epco, Boelaert Marleen, Sundar Shyam
Infectious Disease Research Laboratory, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Lancet Infect Dis. 2016 Dec;16(12):e304-e309. doi: 10.1016/S1473-3099(16)30140-2. Epub 2016 Sep 28.
Visceral leishmaniasis is a serious public health problem on the Indian subcontinent, causing high morbidity and mortality. The governments in the region launched a visceral leishmaniasis elimination initiative in 2005. We review knowledge gaps and research priorities. Key challenges include low coverage of health services for those most at risk, drug resistance, the absence of a vaccine, and the complex biology of the sandfly-human host transmission cycle. Vector control is an essential component, but innovation in this field is insufficient. Substantial progress has been made in the area of diagnostic, therapeutic, and vaccine development, but there are still many hurdles to overcome. For visceral leishmaniasis elimination to become a reality, effective deployment of these existing and new tools is essential. A strong commitment at community level is imperative, and appropriate diagnostic and treatment services as well as effective epidemiological surveillance need to be ensured.
内脏利什曼病是印度次大陆上一个严重的公共卫生问题,会导致高发病率和高死亡率。该地区各国政府于2005年发起了一项消除内脏利什曼病的倡议。我们回顾了知识空白和研究重点。主要挑战包括对高危人群的卫生服务覆盖率低、耐药性、缺乏疫苗以及白蛉-人类宿主传播循环的复杂生物学特性。病媒控制是一个重要组成部分,但该领域的创新不足。在诊断、治疗和疫苗开发领域已取得了重大进展,但仍有许多障碍需要克服。要使消除内脏利什曼病成为现实,有效部署这些现有和新工具至关重要。社区层面必须做出坚定承诺,同时需要确保提供适当的诊断和治疗服务以及有效的流行病学监测。